Filter Results:
- Full text PDF available (6)
Publication Year
1977
2018
- This year (2)
- Last 5 years (11)
- Last 10 years (22)
Publication Type
Co-author
Journals and Conferences
Learn More
- Mauro Di Ianni, Franca Falzetti, +19 authors Massimo Fabrizio Martelli
- Blood
- 2011
Hastening posttransplantation immune reconstitution is a key challenge in human leukocyte antigen (HLA)-haploidentical hematopoietic stem-cell transplantation (HSCT). In experimental models of… (More)
- Loredana Ruggeri, Antonella Mancusi, +12 authors Andrea Velardi
- Blood
- 2007
We analyzed 112 patients with high-risk acute myeloid leukemia (61 in complete remission [CR]; 51 in relapse), who received human leukocyte-antigen (HLA)-haploidentical transplants from natural… (More)
- Franco Aversa, Adelmo Terenzi, +15 authors Massimo Fabrizio Martelli
- Journal of clinical oncology : official journal…
- 2005
PURPOSE
Establishment of hematopoietic stem-cell (HSC) transplantation from mismatched relatives is feasible for patients with acute leukemia. As our original method of graft processing was… (More)
- Cristina Cunha, Mauro Di Ianni, +15 authors António Carvalho
- Blood
- 2010
The C-type lectin receptor Dectin-1 plays a pivotal role in antifungal immunity. In this study, the recently characterized human DECTIN1 Y238X early stop codon polymorphism leading to diminished… (More)
- Massimo Fabrizio Martelli, Mauro Di Ianni, +16 authors Andrea Velardi
- Blood
- 2014
Posttransplant relapse is still the major cause of treatment failure in high-risk acute leukemia. Attempts to manipulate alloreactive T cells to spare normal cells while killing leukemic cells have… (More)
- Katia Perruccio, Antonella Tosti, +10 authors Andrea Velardi
- Blood
- 2005
Aspergillus and cytomegalovirus are major causes of morbidity/mortality after haploidentical hematopoietic transplantation. The high degree of mismatching makes cell immunotherapy impossible as it… (More)
- Franco Aversa, Adelmo Terenzi, +10 authors Massimo Fabrizio Martelli
- Journal of clinical oncology : official journal…
- 1999
PURPOSE
To eliminate the risk of rejection and lower the risk of relapse after T-cell-depleted bone marrow transplants in acute leukemia patients, we enhanced pretransplant immunosuppression and… (More)
- Antonella Mancusi, Loredana Ruggeri, +14 authors Andrea Velardi
- Blood
- 2015
Because activating killer cell immunoglobulinlike receptors (KIRs) are heterogeneously expressed in the population, we investigated the role of donor activating KIRs in haploidentical hematopoietic… (More)
- Vasilis Oikonomou, Silvia Moretti, +15 authors Luigina Romani
- Cell host & microbe
- 2016
Defects in a form of noncanonical autophagy, known as LC3-associated phagocytosis (LAP), lead to increased inflammatory pathology during fungal infection. Although LAP contributes to fungal… (More)
- Loredana Ruggeri, Antonella Mancusi, +6 authors Andrea Velardi
- Blood cells, molecules & diseases
- 2008
As only 60% of leukaemia patients find a matched donor, the Perugia Bone Marrow Transplant Centre developed transplantation from HLA haplotype-mismatched family donors to provide a cure for more… (More)